ACTU
Actuate Therapeutics, Inc.
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:
Float & O/S:
Inst Own:
DilutionScan read 38 of ACTUATE THERAPEUTICS, INC.'s SEC filings and found 8 warrant series, 1 convertible, 1 ATM program, 1 equity line, 1 shelf registration, 3 S-1 registrations and 2 completed offerings on file for ACTU. The latest dilution event on file is an offering on Oct 28, 2026. Analysis updated Oct 28, 2026.
